MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2-advanced breast cancer: the multinational randomized phase III study (2020)
- Authors:
- Autor USP: HEGG, ROBERTO - FM
- Unidade: FM
- DOI: 10.1177/1758835920963925
- Subjects: NEOPLASIAS MAMÁRIAS; MULHERES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Therapeutic advances in medical oncology
- ISSN: 1758-8340
- Volume/Número/Paginação/Ano: v. 12, article ID 1758835920963925, 14p, 2020
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ZHANG, Qing Yuan et al. MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2-advanced breast cancer: the multinational randomized phase III study. Therapeutic advances in medical oncology, v. 12, 2020Tradução . . Disponível em: https://doi.org/10.1177/1758835920963925. Acesso em: 15 fev. 2026. -
APA
Zhang, Q. Y., Sun, T., Yin, Y. M., Li, H. P., Yan, M., Tong, Z. S., et al. (2020). MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2-advanced breast cancer: the multinational randomized phase III study. Therapeutic advances in medical oncology, 12. doi:10.1177/1758835920963925 -
NLM
Zhang QY, Sun T, Yin YM, Li HP, Yan M, Tong ZS, Oppermann CP, Liu YP, Costa R, Hegg R. MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2-advanced breast cancer: the multinational randomized phase III study [Internet]. Therapeutic advances in medical oncology. 2020 ; 12[citado 2026 fev. 15 ] Available from: https://doi.org/10.1177/1758835920963925 -
Vancouver
Zhang QY, Sun T, Yin YM, Li HP, Yan M, Tong ZS, Oppermann CP, Liu YP, Costa R, Hegg R. MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2-advanced breast cancer: the multinational randomized phase III study [Internet]. Therapeutic advances in medical oncology. 2020 ; 12[citado 2026 fev. 15 ] Available from: https://doi.org/10.1177/1758835920963925 - Eficacia, tolerabilidade e aceitabilidade do estradiol transdermico no tratamento dos sintomas da menopausa
- Sindrome do climaterio: conceito, importancia e epidemiologia
- Evaluation the predictive value of biomarkers for efficacy outcomes in response to pertuzumab and trastuzumab based therapy: An exploratory analysis of the tryphaena study
- Câncer da mama: quadro clínico, diagnóstico e estadiamento
- Mastite puerperal
- Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: A randomized phase II cardiac safety study (TRYPHAENA)
- Galactorreia: sindrome hiperprolactinemica
- Genetics of ramucirumab-associated hypertension in the ROSE/TRIO-012 breast cancer trial
- Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer
- Everolimus plus endocrine therapy for postmenopausal women with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer a clinical trial
Informações sobre o DOI: 10.1177/1758835920963925 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
